512217 Stock Overview
Engages in the sale of agriculture products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Prism Medico and Pharmacy Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹24.75 |
| 52 Week High | ₹39.20 |
| 52 Week Low | ₹19.06 |
| Beta | 0.68 |
| 1 Month Change | -0.16% |
| 3 Month Change | -16.24% |
| 1 Year Change | -15.56% |
| 3 Year Change | 128.11% |
| 5 Year Change | 11.74% |
| Change since IPO | 725.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 512217 | IN Food | IN Market | |
|---|---|---|---|
| 7D | 2.3% | 0.4% | -0.3% |
| 1Y | -15.6% | -3.1% | 16.3% |
Return vs Industry: 512217 underperformed the Indian Food industry which returned -2.3% over the past year.
Return vs Market: 512217 underperformed the Indian Market which returned 17.2% over the past year.
Price Volatility
| 512217 volatility | |
|---|---|
| 512217 Average Weekly Movement | 6.4% |
| Food Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: 512217 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 512217's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | n/a | Sakshi Laller | www.prismmedico.in |
Prism Medico and Pharmacy Limited engages in the sale of agriculture products in India. The company was formerly known as Woolite Mercantile Company Limited and changed its name to Prism Medico and Pharmacy Limited in January 2012. Prism Medico and Pharmacy Limited was incorporated in 1985 and is based in Sirmaur, Himachal Pradesh.
Prism Medico and Pharmacy Limited Fundamentals Summary
| 512217 fundamental statistics | |
|---|---|
| Market cap | ₹150.07m |
| Earnings (TTM) | -₹224.00k |
| Revenue (TTM) | ₹29.88m |
5.0x
P/S Ratio-670.0x
P/E RatioIs 512217 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 512217 income statement (TTM) | |
|---|---|
| Revenue | ₹29.88m |
| Cost of Revenue | ₹26.09m |
| Gross Profit | ₹3.79m |
| Other Expenses | ₹4.02m |
| Earnings | -₹224.00k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.037 |
| Gross Margin | 12.69% |
| Net Profit Margin | -0.75% |
| Debt/Equity Ratio | 0% |
How did 512217 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 07:09 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Prism Medico and Pharmacy Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|